“…However, consensus on a standardized pre LT cardiovascular evaluation and risk stratification, even if long and eagerly awaited, is still lacking [1,5,7,9,10,18,20]. Cardiac assessment is then characterized by a large variation in guidelines, with different clinical pathways often "transplant center oriented" and difficult to be generalized, even if the relevant "pillars" sustaining its rationale are common to the various stepwise paradigms [1,9,10,[20][21][22]. As underlined by Sandal et al [10] while in case of symptomatic disease the pathways are quite well defined, risk assessment in the asymptomatic candidate is variable if not sometimes controversial (age of the candidate to perform cardiac stress test or the indication to coronary artery angiography, CA).…”